Nick Glover
Direktor/Vorstandsmitglied bei MEI PHARMA, INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Nick Glover
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MEI PHARMA, INC. | Direktor/Vorstandsmitglied | 11.06.2013 | - |
Independent Dir/Board Member | 11.06.2013 | - | |
Pattern Pharma, Inc.
Pattern Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pattern Pharma, Inc. engages in the pharmaceutical industry. Its product named P2PAR addresses the immune failure which underlies infectious diseases and cancers. The company is headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Nick Glover
Ehemalige bekannte Positionen von Nick Glover
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SIERRA ONCOLOGY, INC. | Direktor/Vorstandsmitglied | 03.09.2014 | 22.05.2020 |
Vorstandsvorsitzender | 03.09.2014 | 22.05.2020 | |
Präsident | 03.09.2014 | 22.05.2020 | |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Direktor/Vorstandsmitglied | 17.01.2011 | 01.02.2013 |
Vorstandsvorsitzender | 01.11.2010 | 01.02.2013 | |
Präsident | 17.01.2011 | 01.02.2013 | |
University Medical Discoveries, Inc.
University Medical Discoveries, Inc. Investment ManagersFinance University Medical Discoveries, Inc. (UMDI) is a venture capital firm located in Toronto. | Private-Equity-Analyst | - | 31.03.2009 |
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Direktor/Vorstandsmitglied | 01.09.2000 | 01.06.2008 |
Vorstandsvorsitzender | 01.09.2000 | 01.06.2008 | |
Präsident | 01.09.2000 | 01.06.2008 | |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Chief Investment Officer | - | - |
Ausbildung von Nick Glover
Simon Fraser University | Doctorate Degree |
University of East Anglia | Undergraduate Degree |
University of British Columbia | Graduate Degree |
Statistik
International
Kanada | 8 |
Vereinigte Staaten | 3 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 5 |
Chief Executive Officer | 3 |
President | 3 |
Sektoral
Health Technology | 6 |
Consumer Services | 4 |
Finance | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MEI PHARMA, INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
University Medical Discoveries, Inc.
University Medical Discoveries, Inc. Investment ManagersFinance University Medical Discoveries, Inc. (UMDI) is a venture capital firm located in Toronto. | Finance |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Health Technology |
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Health Technology |
Sierra Oncology, Inc.
Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA. | Health Technology |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Finance |
Pattern Pharma, Inc.
Pattern Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pattern Pharma, Inc. engages in the pharmaceutical industry. Its product named P2PAR addresses the immune failure which underlies infectious diseases and cancers. The company is headquartered in Toronto, Canada. | Health Technology |
- Börse
- Insiders
- Nick Glover
- Erfahrung